CN119097678A - A Chinese medicine composition for treating pediatric snoring and its application - Google Patents
A Chinese medicine composition for treating pediatric snoring and its application Download PDFInfo
- Publication number
- CN119097678A CN119097678A CN202411371932.7A CN202411371932A CN119097678A CN 119097678 A CN119097678 A CN 119097678A CN 202411371932 A CN202411371932 A CN 202411371932A CN 119097678 A CN119097678 A CN 119097678A
- Authority
- CN
- China
- Prior art keywords
- parts
- snoring
- treating
- pediatric
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 104
- 206010041235 Snoring Diseases 0.000 title claims abstract description 82
- 239000000203 mixture Substances 0.000 title claims abstract description 46
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims abstract description 31
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims abstract description 31
- 230000029058 respiratory gaseous exchange Effects 0.000 claims abstract description 23
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims abstract description 22
- 241000287828 Gallus gallus Species 0.000 claims abstract description 20
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 20
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 20
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 20
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 20
- 241000132012 Atractylodes Species 0.000 claims abstract description 19
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 19
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 19
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 19
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 19
- 244000274050 Platycodon grandiflorum Species 0.000 claims abstract description 19
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 17
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 17
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 17
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 17
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 17
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 17
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 17
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 17
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 17
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 17
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 17
- 239000012528 membrane Substances 0.000 claims abstract description 17
- 244000197580 Poria cocos Species 0.000 claims abstract description 16
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 16
- 235000002226 Ranunculus ficaria Nutrition 0.000 claims abstract description 15
- 210000002534 adenoid Anatomy 0.000 claims abstract description 15
- 206010041349 Somnolence Diseases 0.000 claims abstract description 13
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 10
- 208000032140 Sleepiness Diseases 0.000 claims abstract description 10
- 235000005272 common selfheal Nutrition 0.000 claims abstract description 10
- 208000008967 Enuresis Diseases 0.000 claims abstract description 8
- 235000006751 Platycodon Nutrition 0.000 claims abstract description 8
- 229930189914 platycodon Natural products 0.000 claims abstract description 8
- 208000013403 hyperactivity Diseases 0.000 claims abstract description 7
- 244000081426 Ranunculus ficaria Species 0.000 claims abstract 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- 230000007958 sleep Effects 0.000 claims description 29
- 239000007788 liquid Substances 0.000 claims description 20
- 239000000463 material Substances 0.000 claims description 20
- 229940079593 drug Drugs 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 12
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims description 11
- 238000001914 filtration Methods 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 235000008113 selfheal Nutrition 0.000 claims description 9
- 244000173782 Ficus hirta Species 0.000 claims description 8
- 206010044003 Tonsillar hypertrophy Diseases 0.000 claims description 8
- 208000001705 Mouth breathing Diseases 0.000 claims description 6
- 240000001705 Striga asiatica Species 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- 230000002159 abnormal effect Effects 0.000 claims description 4
- -1 absorption promoters Substances 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 229940124532 absorption promoter Drugs 0.000 claims description 3
- 230000003542 behavioural effect Effects 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000003086 colorant Substances 0.000 claims description 3
- 239000006184 cosolvent Substances 0.000 claims description 3
- 239000003995 emulsifying agent Substances 0.000 claims description 3
- 239000000945 filler Substances 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000013355 food flavoring agent Nutrition 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 239000000080 wetting agent Substances 0.000 claims description 3
- 241000208000 Striga Species 0.000 claims description 2
- 208000027534 Emotional disease Diseases 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- 230000001771 impaired effect Effects 0.000 claims 1
- 208000024891 symptom Diseases 0.000 abstract description 33
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 16
- 210000002741 palatine tonsil Anatomy 0.000 abstract description 14
- 201000010099 disease Diseases 0.000 abstract description 7
- 230000037321 sleepiness Effects 0.000 abstract description 5
- 230000008451 emotion Effects 0.000 abstract description 4
- 206010000117 Abnormal behaviour Diseases 0.000 abstract description 3
- 230000007423 decrease Effects 0.000 abstract description 3
- 206010020880 Hypertrophy Diseases 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 41
- 210000000952 spleen Anatomy 0.000 description 36
- 238000003745 diagnosis Methods 0.000 description 23
- 206010062717 Increased upper airway secretion Diseases 0.000 description 22
- 208000026435 phlegm Diseases 0.000 description 22
- 210000004072 lung Anatomy 0.000 description 20
- 239000002674 ointment Substances 0.000 description 18
- 230000007812 deficiency Effects 0.000 description 17
- 238000011160 research Methods 0.000 description 17
- 238000011282 treatment Methods 0.000 description 17
- 230000000144 pharmacologic effect Effects 0.000 description 15
- 210000001331 nose Anatomy 0.000 description 14
- 230000028327 secretion Effects 0.000 description 14
- 230000001737 promoting effect Effects 0.000 description 13
- 230000006872 improvement Effects 0.000 description 12
- 241001530126 Scrophularia Species 0.000 description 11
- 235000013305 food Nutrition 0.000 description 10
- 208000008784 apnea Diseases 0.000 description 9
- 230000001105 regulatory effect Effects 0.000 description 9
- 210000000492 nasalseptum Anatomy 0.000 description 8
- 208000011580 syndromic disease Diseases 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 7
- 230000036039 immunity Effects 0.000 description 7
- 230000036407 pain Effects 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 238000005728 strengthening Methods 0.000 description 7
- 206010003497 Asphyxia Diseases 0.000 description 6
- 102000004889 Interleukin-6 Human genes 0.000 description 6
- 108090001005 Interleukin-6 Proteins 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 229940100601 interleukin-6 Drugs 0.000 description 6
- 210000004877 mucosa Anatomy 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 210000001944 turbinate Anatomy 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 208000033809 Suppuration Diseases 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000002496 gastric effect Effects 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- 230000027939 micturition Effects 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 239000000341 volatile oil Substances 0.000 description 5
- 102000003777 Interleukin-1 beta Human genes 0.000 description 4
- 108090000193 Interleukin-1 beta Proteins 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 206010042674 Swelling Diseases 0.000 description 4
- 201000003462 adenoid hypertrophy Diseases 0.000 description 4
- 208000022531 anorexia Diseases 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 230000002354 daily effect Effects 0.000 description 4
- 206010061428 decreased appetite Diseases 0.000 description 4
- 230000004069 differentiation Effects 0.000 description 4
- 238000001839 endoscopy Methods 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 210000004907 gland Anatomy 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 239000004382 Amylase Substances 0.000 description 3
- 108010065511 Amylases Proteins 0.000 description 3
- 102000013142 Amylases Human genes 0.000 description 3
- 206010006334 Breathing abnormalities Diseases 0.000 description 3
- 241000675108 Citrus tangerina Species 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 208000007590 Disorders of Excessive Somnolence Diseases 0.000 description 3
- 244000025361 Ficus carica Species 0.000 description 3
- 235000008730 Ficus carica Nutrition 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 235000019418 amylase Nutrition 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000004064 dysfunction Effects 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 230000008897 memory decline Effects 0.000 description 3
- 210000003800 pharynx Anatomy 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 2
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 241000321096 Adenoides Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 108010002350 Interleukin-2 Proteins 0.000 description 2
- 102000000588 Interleukin-2 Human genes 0.000 description 2
- 102000057297 Pepsin A Human genes 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 2
- 206010057190 Respiratory tract infections Diseases 0.000 description 2
- 208000032023 Signs and Symptoms Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 230000002996 emotional effect Effects 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000007661 gastrointestinal function Effects 0.000 description 2
- 208000018997 giddiness Diseases 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000001969 hypertrophic effect Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000010271 massa medicata fermentata Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 208000001797 obstructive sleep apnea Diseases 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 201000002859 sleep apnea Diseases 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 229930182493 triterpene saponin Natural products 0.000 description 2
- LOGFVTREOLYCPF-KXNHARMFSA-N (2s,3r)-2-[[(2r)-1-[(2s)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoic acid Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]1CCCN1C(=O)[C@@H](N)CCCCN LOGFVTREOLYCPF-KXNHARMFSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 244000001632 Acorus gramineus Species 0.000 description 1
- 235000013073 Acorus gramineus Nutrition 0.000 description 1
- 240000008027 Akebia quinata Species 0.000 description 1
- 235000007756 Akebia quinata Nutrition 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- TYPSVDGIQAOBAD-DZGCQCFKSA-N Atractylone Chemical compound C([C@]1(C)C2)CCC(=C)[C@@H]1CC1=C2OC=C1C TYPSVDGIQAOBAD-DZGCQCFKSA-N 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012559 Developmental delay Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010015866 Extravasation Diseases 0.000 description 1
- 241001307997 Ficus hirsuta Species 0.000 description 1
- 241001189830 Fissistigma Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- KVRQGMOSZKPBNS-FMHLWDFHSA-N Harpagoside Chemical compound O([C@@H]1OC=C[C@@]2(O)[C@H](O)C[C@]([C@@H]12)(C)OC(=O)\C=C\C=1C=CC=CC=1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O KVRQGMOSZKPBNS-FMHLWDFHSA-N 0.000 description 1
- KVRQGMOSZKPBNS-BYYMOQGZSA-N Harpagoside Natural products C[C@@]1(C[C@@H](O)[C@@]2(O)C=CO[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H]12)OC(=O)C=Cc4ccccc4 KVRQGMOSZKPBNS-BYYMOQGZSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010021133 Hypoventilation Diseases 0.000 description 1
- 230000004950 I-kappaB phosphorylation Effects 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 102100037850 Interferon gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 102000003945 NF-kappa B Human genes 0.000 description 1
- 108010057466 NF-kappa B Proteins 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 102100029438 Nitric oxide synthase, inducible Human genes 0.000 description 1
- 101710089543 Nitric oxide synthase, inducible Proteins 0.000 description 1
- 206010054107 Nodule Diseases 0.000 description 1
- 102100034404 Nuclear factor of activated T-cells, cytoplasmic 1 Human genes 0.000 description 1
- 101710151542 Nuclear factor of activated T-cells, cytoplasmic 1 Proteins 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241001522129 Pinellia Species 0.000 description 1
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 1
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 235000010674 Prunella vulgaris Nutrition 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 description 1
- 241000207844 Scrophulariaceae Species 0.000 description 1
- 241001591005 Siga Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010067775 Upper airway obstruction Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 208000037883 airway inflammation Diseases 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- RKFAZBXYICVSKP-AATRIKPKSA-N alpha-asarone Chemical compound COC1=CC(OC)=C(\C=C\C)C=C1OC RKFAZBXYICVSKP-AATRIKPKSA-N 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- TYPSVDGIQAOBAD-UHFFFAOYSA-N atractylone Natural products C1C2(C)CCCC(=C)C2CC2=C1OC=C2C TYPSVDGIQAOBAD-UHFFFAOYSA-N 0.000 description 1
- RJWJHRPNHPHBRN-FKVJWERZSA-N aucubin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2C(CO)=C[C@@H](O)[C@@H]2C=CO1 RJWJHRPNHPHBRN-FKVJWERZSA-N 0.000 description 1
- UTDFQMAXCUGNJR-UHFFFAOYSA-N aucubin Natural products OCC1OC(Oc2ccoc2C3C(O)CCC3O)C(O)C(O)C1O UTDFQMAXCUGNJR-UHFFFAOYSA-N 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 108010019077 beta-Amylase Proteins 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000007211 cardiovascular event Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000007213 cerebrovascular event Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000009547 development abnormality Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000036251 extravasation Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000030135 gastric motility Effects 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 230000009546 growth abnormality Effects 0.000 description 1
- 208000037824 growth disorder Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- OLOOJGVNMBJLLR-UHFFFAOYSA-N imperatorin Chemical compound C1=CC(=O)OC2=C1C=C1C=COC1=C2OCC=C(C)C OLOOJGVNMBJLLR-UHFFFAOYSA-N 0.000 description 1
- XKVWLLRDBHAWBL-UHFFFAOYSA-N imperatorin Natural products CC(=CCOc1c2OCCc2cc3C=CC(=O)Oc13)C XKVWLLRDBHAWBL-UHFFFAOYSA-N 0.000 description 1
- 208000022119 inability to concentrate Diseases 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- XDROKJSWHURZGO-UHFFFAOYSA-N isopsoralen Natural products C1=C2OC=CC2=C2OC(=O)C=CC2=C1 XDROKJSWHURZGO-UHFFFAOYSA-N 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000002232 neuromuscular Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- MLMVLVJMKDPYBM-UHFFFAOYSA-N pseudoisopsoralene Natural products C1=C2C=COC2=C2OC(=O)C=CC2=C1 MLMVLVJMKDPYBM-UHFFFAOYSA-N 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 210000001034 respiratory center Anatomy 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 description 1
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 235000019722 synbiotics Nutrition 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 102000003390 tumor necrosis factor Human genes 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8998—Hordeum (barley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Otolaryngology (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating snoring of children and application thereof, and belongs to the technical field of traditional Chinese medicines, wherein the traditional Chinese medicine composition comprises, by weight, 40-60 parts of bighead atractylodes rhizome, 80-100 parts of Chinese yam, 20-50 parts of chicken's gizzard-membrane, 80-100 parts of radix pseudostellariae, 20-40 parts of grassleaf sweelflag rhizome, 20-50 parts of Jianqu, 40-60 parts of dahurian angelica root, 30-50 parts of platycodon root, 20-40 parts of figwort root, 20-55 parts of common selfheal fruit-spike, 80-100 parts of figwort root, 15-35 parts of dried orange peel, 20-30 parts of rhizoma pinellinae praeparata, 15-30 parts of strigostemon striolatum, 30-50 parts of poria cocos, 70-100 parts of lotus seed, 45-65 parts of malt, 25-35 parts of clean hawthorn and 80-110 parts of maltose. The clinical test proves that the traditional Chinese medicine composition can effectively improve the clinical symptoms of snoring, mouth opening and breathing, enuresis, attention decline, hyperactivity, sleepiness, abnormal behaviors and emotion and the like of the infant, reduce the hypertrophy of adenoids and tonsils and effectively avoid the repeated trouble of diseases of the infant.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating pediatric snoring and application thereof.
Background
The snoring disease of children refers to common diseases of otorhinolaryngology, which are caused by partial or complete upper airway obstruction of children in the sleeping process, thereby affecting the ventilation state, the sleeping quality and even the normal growth and development of children. Often, the children sleep at night, such as snoring, mouth opening breathing, apnea or suffocation, enuresis, sleep disorder, daytime attention decline, hyperactivity, sleepiness, abnormal emotion behaviors and the like, and besides the maxillofacial malformation and the growth and development abnormality are caused, the occurrence probability of cardiovascular and cerebrovascular events is possibly increased, so that the children have been increasingly paid attention to parents and society. Snoring in children is mainly caused by adenoid and tonsillar hypertrophy, and can also be related to obesity, abnormal anatomical structure and neuromuscular dysfunction.
The treatment scheme of the snoring disease of children in the prior art is divided into conservative treatment and operation treatment. Western medicine treatment is mainly used for actively treating related diseases such as rhinitis and nasosinusitis which are easy to cause lymphoproliferation, and has the effects of improving immunity of organisms, avoiding respiratory tract infection, improving sleeping habits of children patients, standardizing dietary structures, enhancing lifestyle adjustment such as exercise and the like as auxiliary medicines, and the treatment effects are different from person to person. Surgical treatment is to remove the adenoids and tonsils to open the airways and restore airway width, but it is not guaranteed that recurrence is not longer possible. The traditional Chinese medicine is also internally and externally treated, and traditional Chinese medicine decoction and paste are applied based on syndrome differentiation, and the purposes of relieving symptoms are achieved by taking lung tonifying, middle-jiao strengthening and dampness and phlegm eliminating as methods and combining with the technical methods of exogenous cauterization treatment and choosing treatment.
The snoring seriously jeopardizes the health of children, and the children are treated by adopting an operation cutting method in clinic at present, and although the effect is definite, the acceptance of parts of children is lower, and the postoperative immunity of the children is also affected. The traditional Chinese medicine is used as a more reliable alternative therapy to exert good effect on treating the disease, and has higher safety. For the infant who refuses to receive the operation treatment or has light blockage degree and clinical symptoms still show the initial stage, the treatment of the oral Chinese medicine decoction can be considered at first. The traditional Chinese medicine decoction is prepared by guiding a formula under the concept of syndrome differentiation management of traditional Chinese medicine, selecting the processed decoction pieces and decocting the decoction pieces in water, and can basically achieve the effect of partially relieving the symptoms of the children snoring patients with different syndrome types and different constitutions. However, due to the differentiation of doctors, the traditional Chinese medicinal materials and the dosage thereof are always not completely consistent, and the quality, the variety and the like of the medicinal materials have influence on the actual curative effect.
In view of the above, the inventors have made intensive studies to solve the above-mentioned problems, and have made the present invention.
Disclosure of Invention
In order to solve the problems that the traditional Chinese medicinal materials and the dosages thereof which are selected by doctors are always not completely consistent and the actual curative effects are not uniform due to differentiation of symptoms, the inventor verifies that the traditional Chinese medicinal composition for treating the pediatric snore and the application thereof are obtained through clinical research, and the traditional Chinese medicinal composition is widely applicable to preventing and treating the pediatric snore and improving the children bad physique.
The invention provides a traditional Chinese medicine composition for treating snoring of children, which comprises, by weight, 40-60 parts of bighead atractylodes rhizome, 80-100 parts of Chinese yam, 20-50 parts of chicken's gizzard-membrane, 80-100 parts of radix pseudostellariae, 20-40 parts of grassleaf sweelflag rhizome, 20-50 parts of Jianqu, 40-60 parts of radix angelicae, 30-50 parts of platycodon grandiflorum, 20-40 parts of radix scrophulariae, 20-55 parts of selfheal, 80-100 parts of figwort, 15-35 parts of dried orange peel, 20-30 parts of rhizoma pinellinae praeparata, 15-30 parts of striga asiatica, 30-50 parts of poria cocos, 70-100 parts of lotus seeds, 45-65 parts of malt, 25-35 parts of clean hawthorn and 80-110 parts of maltose.
The preparation method comprises the following raw materials, by weight, 45-55 parts of bighead atractylodes rhizome, 90-100 parts of Chinese yam, 30-45 parts of chicken's gizzard-membrane, 95-100 parts of radix pseudostellariae, 35-40 parts of grassleaf sweelflag rhizome, 40-50 parts of Jianqu, 45-55 parts of radix angelicae, 35-45 parts of platycodon grandiflorum, 25-35 parts of figwort root, 45-55 parts of common selfheal fruit-spike, 90-100 parts of Ficus hirsuta, 15-20 parts of dried orange peel, 25-30 parts of rhizoma pinellinae praeparata, 20-30 parts of strigosa, 45-50 parts of poria cocos, 80-95 parts of lotus seeds, 45-50 parts of malt, 25-30 parts of clean hawthorn and 80-100 parts of maltose.
The Chinese medicinal composition comprises, by weight, 50 parts of bighead atractylodes rhizome, 100 parts of Chinese yam, 40 parts of chicken's gizzard-membrane, 100 parts of radix pseudostellariae, 40 parts of grassleaf sweelflag rhizome, 50 parts of Jianqu, 50 parts of dahurian angelica root, 40 parts of platycodon root, 30 parts of figwort root, 50 parts of common selfheal fruit-spike, 100 parts of figwort root, 20 parts of dried orange peel, 30 parts of rhizoma pinellinae praeparata, 25 parts of strigosae radix, 50 parts of poria cocos, 90 parts of lotus seed, 50 parts of malt, 30 parts of clean hawthorn and 90 parts of maltose.
The second aspect of the invention provides application of the traditional Chinese medicine composition in preparing and/or treating the medicines for treating the pediatric snoring.
As a preferred embodiment, the pediatric snoring disease includes pediatric adenoids and tonsillar hypertrophy.
The third aspect of the invention provides a traditional Chinese medicine composition for treating pediatric snoring and pharmaceutically acceptable auxiliary materials, wherein the auxiliary materials comprise at least one or more of disintegrating agents, emulsifying agents, fillers, flavoring agents, wetting agents, adhesives, absorption promoters, coloring agents and cosolvent.
In some more preferred embodiments, the dosage form of the medicament comprises one or more of paste, decoction, granule, pill, capsule, tablet, mixture, suspension, powder or oral liquid.
In some more preferred embodiments, the medicament is a medicament for improving sleep snoring, open mouth breathing, sleep breathing abnormalities, enuresis, attention loss, hyperactivity, somnolence, behavioral and emotional abnormalities, adenoids, and tonsillar hypertrophy.
The fourth aspect of the invention provides a preparation method of the Chinese medicinal ointment, which comprises the following steps:
weighing all the raw materials except maltose according to the weight portion, adding purified water and soaking;
Step two, extracting the crude drugs for three times, collecting the extracting solution and filtering;
And thirdly, adding maltose after filtering and concentrating to obtain the product.
In some more preferred embodiments, the step one is performed by adding 6 times of water to the drug substance and soaking for at least 12 hours;
The extraction process in the second step comprises collecting liquid medicine after 1.5 hours of first decoction, collecting liquid medicine after 1 hour of second decoction and adding 6 times of water of the total raw materials, and collecting liquid medicine after the third decoction and adding 3 times of water of the total raw materials, collecting liquid medicine after 1 hour of decoction, combining the three extraction filtrates, and filtering.
The recipe takes the actions of regulating qi movement and assisting spleen and stomach movement as the main actions of resolving phlegm and nourishing lung and spleen qi. Wherein, the radix pseudostellariae, the poria cocos, the rhizoma atractylodis macrocephalae and the rhizoma dioscoreae are capable of strengthening spleen and tonifying qi, the lotus seeds are capable of promoting diuresis, the platycodon grandiflorum and the liquorice are capable of diffusing lung and relieving sore throat, the qi of the lung and spleen is mainly transported, the spleen is cleared away, the qi of the pinellia ternate is reduced, and the rhizoma atractylodis macrocephalae is combined to play the roles of strengthening spleen and resolving phlegm, and the qi is regulated and tonifying lung. The prescription is added with some special medicinal materials of Ling nan, such as Jianqu, haw, chicken's gizzard-skin and malt for resolving food stagnation and resolving food stagnation, dahurian angelica root and grassleaf sweelflag rhizome for resolving dampness, assisting in diffusing and relieving stuffy nose, and Ficus simplicissima for replenishing qi and invigorating spleen for resolving dampness, resolving phlegm and eliminating snore. The striga asiatica is added as a dried whole herb of strigae asiatica of the figwort family, is mainly produced in Guangdong and Guangxi Provinces areas, is a traditional medicinal plant in the folk of Ling nan, has the effects of clearing heat and removing food retention, and is a good medicine for treating infantile malnutrition. The selfheal can relieve sore throat and detumescence, and disperse hypertrophic adenoids and tonsils in the prescription, so as to assist in inducing resuscitation and eliminating snoring, and the components are synergistic, so that the composition fully plays the advantages of various medicines, and the overall curative effect is improved.
The technical scheme of the invention has the following beneficial effects:
the invention provides a traditional Chinese medicine composition for treating child snoring and accompanying diseases, wherein the traditional Chinese medicine composition is prepared from Massa Medicata Fermentata, fructus crataegi, endothelium corneum Gigeriae Galli and malt for resolving food stagnation and resolving food stagnation, radix Angelicae Dahuricae and rhizoma Acori Graminei for resolving dampness, promoting the dispersing function of nose and orifice, and radix fici simplicissimae for invigorating qi, and has the effects of resolving phlegm and eliminating snoring by strengthening spleen and eliminating dampness, thus helping child to improve other body dysfunction caused by bad life habits, and fundamentally treating child snoring. Clinical experiments prove that the medicine composition can effectively improve the clinical symptoms of snoring, mouth opening breathing, enuresis, attention loss, hyperactivity, somnolence, abnormal behaviors and emotion and the like of the infant, reduce the enlarged adenoids and tonsils and effectively avoid the repeated trouble of diseases of the infant.
Detailed Description
For the purpose of making the objects, technical solutions and advantages of the embodiments of the present invention more clear, the technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is apparent that the described embodiments are some embodiments of the present invention, but not all embodiments. Thus, the following detailed description of the embodiments of the invention is not intended to limit the scope of the invention, as claimed, but is merely representative of selected embodiments of the invention. All other embodiments, which can be made by those skilled in the art based on the embodiments of the present invention without making any inventive effort, are intended to fall within the scope of the present invention.
The inventor verifies through clinical research that the composition for treating the child snoring disease, the preparation method and the application thereof are widely applicable to treating the child snoring disease, improving the weak constitution of children, and especially having a certain curative effect in the early stage of the child snoring disease. The specific implementation mode is as follows:
The invention provides a traditional Chinese medicine composition for treating child snoring, which comprises, by weight, 40-60 parts of bighead atractylodes rhizome, 80-100 parts of Chinese yam, 20-50 parts of chicken's gizzard-membrane, 80-100 parts of radix pseudostellariae, 20-40 parts of grassleaf sweelflag rhizome, 20-50 parts of Jianqu, 40-60 parts of dahurian angelica root, 30-50 parts of platycodon root, 20-40 parts of figwort root, 20-55 parts of common selfheal fruit-spike, 80-100 parts of Ficus simplicissima, 15-35 parts of dried orange peel, 20-30 parts of rhizoma pinellinae praeparata, 15-30 parts of striga decumbens, 30-50 parts of poria cocos, 70-100 parts of lotus seed, 45-65 parts of malt, 25-35 parts of net hawthorn and 80-110 parts of maltose.
The traditional Chinese medicine composition for treating the snoring of children is prepared from 45-55 parts of bighead atractylodes rhizome, 90-100 parts of Chinese yam, 30-45 parts of chicken's gizzard-membrane, 95-100 parts of radix pseudostellariae, 35-40 parts of grassleaf sweelflag rhizome, 40-50 parts of Jianqu, 45-55 parts of radix angelicae, 35-45 parts of platycodon grandiflorum, 25-35 parts of figwort root, 45-55 parts of common selfheal fruit-spike, 90-100 parts of figwort root, 15-20 parts of dried orange peel, 25-30 parts of rhizoma pinellinae praeparata, 20-30 parts of striga asiatica, 45-50 parts of poria cocos, 80-95 parts of lotus seed, 45-50 parts of malt, 25-30 parts of clean hawthorn and 80-100 parts of maltose.
The traditional Chinese medicine composition for treating the snoring of children comprises 50 parts of bighead atractylodes rhizome, 100 parts of Chinese yam, 40 parts of chicken's gizzard-membrane, 100 parts of radix pseudostellariae, 40 parts of grassleaf sweelflag rhizome, 50 parts of massa medicata fermentata, 50 parts of radix angelicae, 40 parts of platycodon grandiflorum, 30 parts of radix scrophulariae, 50 parts of selfheal, 100 parts of fiveleaf fissistigma root, 20 parts of dried orange peel, 30 parts of rhizoma pinellinae praeparata, 25 parts of striga asiatica, 50 parts of poria cocos, 90 parts of lotus seed, 50 parts of malt, 30 parts of net hawthorn and 90 parts of maltose.
Under the above formula proportion, the medicine for treating snoring provided by the invention can effectively treat snoring symptoms and obviously improve sleeping quality. Meanwhile, the medicine for treating snoring can be prepared into pills, decoction and the like, and can also be prepared into injection, powder and other formulations.
The second aspect of the invention provides application of the traditional Chinese medicine composition in preparing and/or treating the medicines for treating the pediatric snoring.
As a preferred embodiment, the pediatric snoring disease includes pediatric adenoids and tonsillar hypertrophy.
The third aspect of the invention provides a traditional Chinese medicine composition for treating pediatric snoring and pharmaceutically acceptable auxiliary materials, wherein the auxiliary materials comprise at least one or more of disintegrating agents, emulsifying agents, fillers, flavoring agents, wetting agents, adhesives, absorption promoters, coloring agents and cosolvent.
In some more preferred embodiments, the dosage form of the medicament comprises one or more of paste, decoction, granule, pill, capsule, tablet, mixture, suspension, powder or oral liquid.
Because of the consideration of some characteristics of children when taking medicines, it is preferable here that the paste is a more preferable dosage form. The Chinese medicinal materials are repeatedly decocted, filtered and concentrated to prepare the paste, a plurality of decoction parts are added into one part, the paste is spooned out and is brewed with warm boiled water when taken, the paste is simple and easy to operate, has the same curative effect as the decoction, does not contain high-animal high-protein components such as honey, donkey-hide gelatin and the like, reduces the risk of anaphylactic reaction of the infant, and the auxiliary material is maltose, namely maltose, has no influence on gastrointestinal burden of the infant, and can be used all the year round without being limited in autumn and winter.
In some more preferred embodiments, the medicament is a medicament for improving sleep snoring, open mouth breathing, sleep breathing abnormalities, enuresis, attention loss, hyperactivity, somnolence, behavioral and emotional abnormalities, adenoids, and tonsillar hypertrophy.
The fourth aspect of the invention provides a preparation method of the Chinese medicinal ointment, which comprises the following steps:
weighing all the raw materials except maltose according to the weight portion, adding purified water and soaking;
Step two, extracting the crude drugs for three times, collecting the extracting solution and filtering;
And thirdly, adding maltose after filtering and concentrating to obtain the product.
In some of the more preferred embodiments thereof,
Adding 6 times of water into the crude drugs in the first step for at least 12 hours;
in the second step, the decoction temperature is set to be 100 ℃, the operation is carried out under micro pressure for 1 hour, the liquid medicine is collected after the first decoction is carried out for 1.5 hours, the liquid medicine is collected after the second decoction is added with 6 times of the total raw material medicine and is decocted for 1 hour, the liquid medicine is collected after the third decoction is added with 3 times of the total raw material medicine and is decocted for 1 hour, the liquid medicine is collected after the third decoction is carried out, and the three extraction filtrates are combined and filtered.
And in the third step, when the paste is produced, adding maltose into the clear paste, when the liquid medicine is not boiled and foamed, preparing the paste, stirring until the paste is drawn into a flag, hung on the wire or dripped into a bead, dripping the paste juice into clear water to be coagulated into the bead without dispersion, and finally placing the paste into a cold paste cabinet for standing overnight.
In the invention, the radix pseudostellariae in the traditional Chinese medicine composition has the effects of replenishing qi to invigorate the spleen, promoting the production of body fluid and moistening the lung. It is mainly used for treating anorexia, palpitation, insomnia, deficiency heat and excessive sweat. Modern pharmacological research shows that the radix pseudostellariae peptide, which is a radix pseudostellariae protein hydrolysate, caN promote spleen T lymphocytes to release TNF-alpha, INF-gamma and IL-10 by activating Ca 2+/CaN/NFATc 1/IFN-gamma channels, thereby playing an immune enhancing role. The Ficus simplicissima lour has effects of invigorating spleen, nourishing lung, promoting qi circulation, removing dampness, relieving rigidity of muscles and activating collaterals. It has effects in treating spleen deficiency edema, anorexia, cough due to tuberculosis, night sweat, leukorrhagia, puerperal agalactia, rheumatalgia, edema, ascites due to liver cirrhosis, hepatitis, and traumatic injury. Radix scrophulariae has effects of clearing heat and cooling blood, nourishing yin and lowering fire, removing toxic substance and resolving hard mass. It has the effects of clearing heat, nourishing blood, warming toxin, resolving macula, expelling yin, relieving constipation, relieving cough due to bone steaming, conjunctival congestion, pharyngalgia, scrofula, diphtheria, carbuncle, swelling and sore. Modern pharmacological research shows that figwort contains iridoid compounds such as harpagoside, aucubin and the like, and has the function of enhancing immunity. The three are all monarch drugs.
Wherein, the Chinese yam has the effects of tonifying qi and yin, tonifying spleen, lung and kidney, and securing essence and stopping seminal emission, and is mainly used for treating spleen and stomach weakness, lung and kidney weakness and diabetes with internal heat due to yin deficiency. Modern pharmacological research shows that the nano Chinese yam polysaccharide bifidobacterium synbiotic colon targeting microecological regulator can reduce intestinal inflammation, improve the level of hemolysin, the content of sIgA and GM-CSF, reduce the content of IL-1 beta, IL-6 and TNF-alpha, and improve the immunity of organisms. The bighead atractylodes rhizome has the effects of tonifying qi and strengthening spleen, drying dampness and promoting diuresis, strengthening exterior and arresting sweating, is mainly used for treating deficiency of spleen and stomach qi, anorexia and loose stool, abdominal distention and fatigue of limbs, phlegm fluid, edema, dysuria and the like caused by spleen deficiency and transportation failure and water dampness internal stop, and symptoms of spleen deficiency and weak qi, unstable muscle surface and spontaneous sweat, and modern pharmacological researches show that the bighead atractylodes rhizome contains atractylone, atractylenolide A, B, saccharides (mainly mannose and fructose) and the like, has the effects of regulating immunity, and can obviously enhance the expression of interleukin-2 (IL-2) receptors on the surface of peripheral blood lymph running of a human body. Poria has effects of promoting diuresis, removing dampness, invigorating spleen, and calming heart. Is mainly used for treating edema, difficult urination, spleen deficiency diarrhea, palpitation, insomnia and phlegm retention. Modern pharmacological studies have shown that poria ethanol extracts exert an effect of treating inflammation by inhibiting the inactivation of iNOS, COX-2, IL-1 beta levels and TNF-alpha/NF- κb signaling pathways, with the inflammatory response of macrophages as a target. The lotus seeds have the effects of tonifying spleen and relieving diarrhea, stopping leukorrhagia, tonifying kidney and astringing essence, and nourishing heart and soothing nerves, and are mainly used for treating spleen deficiency diarrhea, leukorrhagia, spermatorrhea, palpitation and insomnia. Modern pharmacological researches show that lotus seed contains raffinose and has the functions of enhancing immunity, increasing bifidobacteria, bidirectionally regulating gastrointestinal function, tranquilizing, improving sleep, promoting lipolysis and the like. The pericarpium Citri Tangerinae has effects of regulating qi-flowing, invigorating spleen, eliminating dampness and resolving phlegm, and can be used for treating abdominal distention and pain, anorexia, emesis, singultus, phlegm dampness chest distress, cough and asthma. Modern pharmacological research shows that pericarpium citri reticulatae contains volatile oil, and the fat-soluble component d-limonene of the pericarpium citri reticulatae is regarded as an expectorant medicinal effect component. The tangerine peel essential oil can block NF-kappa B, JNK, ERK signal path to play anti-inflammatory role, the mechanism of the tangerine peel essential oil is related to the expression of inflammatory cytokines and pro-inflammatory mediators tumor necrosis factor (TNF-alpha), interleukin-1 beta (IL-1 beta) and interleukin-6 (IL-6) in macrophages, and the tangerine peel essential oil can also improve cell migration and protein extravasation and play remarkable anti-inflammatory role. Rhizoma Pinelliae Preparata has effects of eliminating dampness and phlegm, dispelling pathogenic wind and relieving spasm, and can be used for treating giddiness, apoplexy, epilepsia, tetanus, carbuncle, swelling and pain, scrofula, phlegm nodule, and venomous snake bite caused by damp phlegm, cold phlegm and wind phlegm. Modern pharmacological research shows that the rhizoma Pinelliae Preparata water extractive solution can reduce secretion of cell inflammatory factors interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha), improve airway inflammation, inhibit p38 and IκB phosphorylation, and down regulate IL-6 and IL-8 content in bronchoalveolar lavage fluid of mice with airway symptoms. Rhizoma Acori Graminei has effects of inducing resuscitation, eliminating phlegm, refreshing mind, improving intelligence, eliminating dampness, and stimulating appetite, and can be used for treating stuffiness, unconsciousness, epilepsia, amnesia, insomnia, tinnitus, deafness, damp obstruction of middle energizer, gastric fullness, hunger, and vomiting dysentery. Modern pharmacological research shows that the volatile oil of grassleaf sweelflag rhizome contains asarone, dan Changmi and other components, and has the functions of tranquilizing, improving learning and memory, resisting heart and brain ischemia loss, regulating gastrointestinal motility and the like. The seven components are taken as ministerial drugs.
The Jian qu has the effects of promoting digestion, resolving food stagnation, regulating qi, resolving dampness and dispersing wind-cold, and is mainly used for treating food stagnation and wind-cold exterior syndrome. Radix Angelicae Dahuricae has effects of relieving exterior syndrome, dispelling cold, dispelling pathogenic wind, relieving pain, eliminating dampness, relieving leukorrhagia, relieving swelling, expelling pus, and relieving stuffy nose, and can be used for treating various pains, and can be used for treating nasal obstruction, skin ulcer, skin pruritus, and leukorrhagia. Modern pharmacological researches show that the angelica dahurica contains various leguminous compounds such as imperatorin, angelicin and the like, and the small dose has excitation effect on respiratory centers and also has anti-inflammatory effect. The fructus crataegi has effects of resolving food stagnation, invigorating stomach, promoting qi circulation, removing blood stasis, eliminating turbid pathogen, and reducing blood lipid, and can be used for treating dyspepsia, diarrhea dysentery, blood stasis, and hyperlipidemia, and fructus crataegi mainly contains flavonoids, triterpene saponins, saponin tannins, free acid, fatty acid, vitamin C, inorganic salt, and red pigment. Modern pharmacological research shows that fatty acid contained in the clean haw can promote fat digestion, increase secretion of gastric digestive enzyme to promote digestion, and has certain regulation effect on gastrointestinal function. Radix et rhizoma Rhei has effects of invigorating spleen, resolving food stagnation, suppressing hyperactive liver, clearing heat and promoting urination, and can be used for treating infantile dyspepsia, malnutritional stagnation and dysuria. The malt has the effects of promoting digestion, regulating middle warmer, promoting lactation and relieving distention, and is mainly used for treating indigestion. Modern pharmacological research shows that malt contains alpha-amylase, beta-amylase, catalytic enzyme, maltose, barley malt alkali and other components, and the contained amylase can promote digestion, decoction can promote gastric acid and pepsin secretion, and water decoction contains pancreatic amylase activator. The chicken's gizzard-membrane has the effects of promoting digestion, invigorating stomach, stopping seminal emission, treating stranguria and resolving stone, and is mainly used for treating food stagnation, seminal emission, enuresis and sandstone stranguria. Modern pharmacological research shows that chicken's gizzard-membrane contains gastric hormone, keratin, trace pepsin, amylase and other components, and can raise gastric secretion and acidity and strengthen gastric motility and digestive enzyme activity. Prunella vulgaris has effects of clearing heat and purging pathogenic fire, improving eyesight, detumescence and resolving hard mass, and can be used for treating conjunctival congestion and swelling pain, headache and giddiness, scrofula, goiter, acute mastitis, and nodules of breast. Modern pharmacological research shows that selfheal contains organic acid components such as rosmarinic acid and the like and has the function of resisting pathogenic microorganisms. Radix Platycodi has effects of dispersing lung qi, eliminating phlegm, expelling pus, relieving sore throat, and can be used for treating cough with excessive phlegm, chest distress, lung abscess due to heat toxin obstruction of lung, laryngopharynx swelling and pain, and aphonia. Modern pharmacological researches show that the platycodon grandiflorum contains various saponins and polysaccharides, mainly triterpene saponins, and has the effects of resisting inflammation, calming, regulating immunity, eliminating phlegm, relieving cough, relieving asthma and the like. The eight components are used as adjuvant drugs.
The maltose has sweet taste, warm nature, and spleen, stomach and lung meridian, has effects of invigorating spleen and replenishing qi, relieving spasm and pain, moistening lung and relieving cough, and can be used for treating fatigue, spleen injury, acute abdominal pain, cough due to lung dryness, hematemesis, thirst, pharyngalgia, and constipation.
The clinical test results show that the traditional Chinese medicine composition can effectively improve the clinical symptoms such as snoring, mouth opening respiration, sleep breathing abnormality, enuresis, attention decline, hyperactivity, somnolence, abnormal behaviors and emotion and the like during sleeping, reduce the volumes of adenoids and tonsils, and effectively treat the snoring of children.
The invention is described in further detail below in connection with the following detailed description:
Example 1
A Chinese medicinal composition in the form of ointment
The traditional Chinese medicine composition is prepared from the following medicinal materials, by weight, 50 parts of bighead atractylodes rhizome, 100 parts of Chinese yam, 40 parts of chicken's gizzard-membrane, 100 parts of radix pseudostellariae, 40 parts of rhizoma acori graminei, 50 parts of Jianqu, 50 parts of radix angelicae, 40 parts of platycodon grandiflorum, 30 parts of radix scrophulariae, 50 parts of selfheal, 100 parts of Ficus carica, 20 parts of dried orange peel, 30 parts of rhizoma pinellinae praeparata, 25 parts of strigosa, 50 parts of poria cocos, 90 parts of lotus seed, 50 parts of malt, 30 parts of net hawthorn and 90 parts of maltose.
Weighing the first 18 medicinal materials except maltose, adding 6 times of water, soaking for 12 hours, setting the decoction temperature to 100 ℃, preserving for 1 hour, operating under micro-pressure, performing first decoction, extracting for 1.5 hours, collecting the liquid medicine, performing second decoction, adding 6 times of water into filter residues, extracting for 1 hour, collecting the liquid medicine, performing third decoction, adding 3 times of water into the filter residues, extracting for 1 hour, collecting the liquid medicine, and combining the three extracted liquid medicines and filtering. Heating for concentrating, adding 90 parts of maltose, stirring continuously when changing into concentrated solution, drawing into flag, hanging wire or dripping water into beads, dripping the extract into clear water to coagulate into beads without dispersion, dripping the obtained extract onto mulberry paper, and transferring into sterile bottle without water seepage for sealing and preservation.
Example 2
Ointment (II) for preparing the Chinese medicinal composition
The traditional Chinese medicine composition is prepared from the following medicinal materials, by weight, 45 parts of bighead atractylodes rhizome, 100 parts of Chinese yam, 30 parts of chicken's gizzard-membrane, 100 parts of radix pseudostellariae, 20 parts of grassleaf sweelflag rhizome, 40 parts of Jianqu, 45 parts of dahurian angelica root, 35 parts of platycodon root, 30 parts of figwort root, 45 parts of common selfheal fruit-spike, 100 parts of Ficus carica, 20 parts of dried orange peel, 25 parts of rhizoma pinellinae praeparata, 30 parts of strigosae, 45 parts of poria cocos, 95 parts of lotus seed, 65 parts of malt, 25 parts of net hawthorn and 80 parts of maltose. Wherein the ointment is prepared in the same way as in example 1.
Example 3
Ointment (III) for preparing the Chinese medicinal composition
The Chinese medicinal materials are weighed according to the weight parts of 60 parts of bighead atractylodes rhizome, 100 parts of Chinese yam, 45 parts of chicken's gizzard-membrane, 100 parts of radix pseudostellariae, 40 parts of grassleaf sweelflag rhizome, 50 parts of Jianqu, 40 parts of dahurian angelica root, 50 parts of platycodon root, 30 parts of figwort root, 50 parts of common selfheal fruit-spike, 100 parts of fimbriata, 25 parts of dried orange peel, 30 parts of rhizoma pinellinae praeparata, 30 parts of strigosae radix, 50 parts of Indian buead, 100 parts of lotus seed, 60 parts of malt, 35 parts of clean hawthorn and 100 parts of maltose. Wherein the ointment is prepared in the same way as in example 1.
Example 4
Ointment (IV) for preparing the Chinese medicinal composition
The traditional Chinese medicine composition is prepared from 40 parts of bighead atractylodes rhizome, 80 parts of Chinese yam, 20 parts of chicken's gizzard-membrane, 100 parts of radix pseudostellariae, 20 parts of rhizoma acori graminei, 20 parts of Jianqu, 40 parts of radix angelicae, 30 parts of platycodon grandiflorum, 20 parts of radix scrophulariae, 45 parts of selfheal, 100 parts of Ficus simplicissima lour, 19 parts of dried orange peel, 25 parts of rhizoma pinellinae praeparata, 15 parts of strigosa, 45 parts of poria cocos, 80 parts of lotus seed, 55 parts of malt, 25 parts of net hawthorn and 80 parts of maltose. Wherein the ointment is prepared in the same way as in example 1.
Example 5
Ointment (five) for preparing the Chinese medicinal composition
The traditional Chinese medicine composition is prepared from 60 parts of bighead atractylodes rhizome, 100 parts of Chinese yam, 50 parts of chicken's gizzard-membrane, 100 parts of radix pseudostellariae, 40 parts of rhizoma acori graminei, 50 parts of Jianqu, 60 parts of radix angelicae, 50 parts of platycodon grandiflorum, 30 parts of radix scrophulariae, 55 parts of selfheal, 100 parts of Ficus simplicissima lour, 35 parts of dried orange peel, 30 parts of rhizoma pinellinae praeparata, 30 parts of strigosa, 50 parts of poria cocos, 100 parts of lotus seed, 65 parts of malt, 35 parts of net hawthorn and 110 parts of maltose. Wherein the ointment is prepared in the same way as in example 1.
Example 6
Preparation of paste (six) of the Chinese medicinal composition of the invention
The traditional Chinese medicine composition is prepared from the following medicinal materials, by weight, 50 parts of bighead atractylodes rhizome, 100 parts of Chinese yam, 40 parts of chicken's gizzard-skin, 100 parts of radix pseudostellariae, 40 parts of grassleaf sweelflag rhizome, 50 parts of Jianqu, 40 parts of dahurian angelica root, 45 parts of platycodon root, 35 parts of brown, 45 parts of common selfheal fruit-spike, 100 parts of Ficus simplicissima lour, 25 parts of dried orange peel, 25 parts of rhizoma pinellinae praeparata, 25 parts of strigosae, 50 parts of poria cocos, 95 parts of lotus seed, 55 parts of malt, 30 parts of net hawthorn and 90 parts of maltose. Wherein the ointment is prepared in the same way as in example 1.
Example 7
Clinical trials of the Chinese medicinal composition of the invention
1 Materials and methods
1.1 Study and grouping
50 Cases of patients with the age of 3-10 years, diagnosed snoring of children and at least 250 g of the ointment prepared in the example 1 are randomly selected for diagnosis in the ear-nose-throat clinic of the first affiliated hospital of Guangzhou university of traditional Chinese medicine from 2023 month 11 to 2024 month 5. Clinical symptoms and signs before and after taking the paste are recorded in the form of clinic and electronic medical record system acquisition and telephone follow-up, and the curative effect of the paste for treating the snore of children is compared and evaluated through improvement of the clinical symptoms and signs.
1.2 Diagnostic criteria
Western diagnosis standard (1) snoring with open mouth breathing when the infant sleeps, sleep apnea or suffocation, sleepiness or slow reaction in daytime, growth and dysplasia when the serious infant sleeps, (2) adenoid face, (3) endoscopic examination prompts adenoid hypertrophy and (or) tonsil hypertrophy, and (4) polysomnography results prompt the existence of simple snoring or obstructive sleep apnea hypoventilation syndrome.
The traditional Chinese medicine diagnosis standard is prepared by referring to the content of a national advanced traditional Chinese medicine education and family planning teaching material 'science of ear nose and throat of traditional Chinese medicine' science 'and' common knowledge of the Chinese medical science 'Chinese medical science of snoring disease' on the 2019 edition, wherein (1) snoring disease is mainly represented by sleeping, accompanied by mouth opening and breathing, and has the symptoms of apnea or suffocation, dysphoria, sleepiness, concentration failure, reaction retardation, growth and development disorder in the daytime, (2) the symptoms of ① phlegm-dampness internal resistance, ② qi deficiency and phlegm stasis, ③ lung-spleen qi deficiency, ④ spleen-kidney deficiency and ⑤ can not be classified as other symptoms of the four types.
1.3 Inclusion and exclusion criteria
Inclusion criteria:
(1) The first diagnosis accords with the traditional Chinese medicine pediatric snore diagnosis standard, western medicine-children simple snore and children obstructive sleep apnea hypopnea syndrome diagnosis standard.
(2) The patient has the advantages of 3-10 years old, unlimited sex, strong compliance, and can complete the course of treatment by being matched with medicine taking, and the patient can agree with the informed condition.
(3) The nasal endoscopic adenoids are blocked by less than 70% of nostrils, and the tonsils are 1-3 degrees hypertrophic.
(4) Refusing the operation treatment, and no obvious deflection of nasal septum or abnormal nasal anatomy structure.
(5) Is suitable for the syndrome of qi deficiency of lung and spleen, spleen and stomach weakness and phlegm dampness stagnation in the traditional Chinese medicine.
Exclusion criteria:
(1) Serious diseases of cardiovascular and cerebrovascular diseases, mental diseases and other systems are combined.
(2) There is a history of acute respiratory infections or an onset of acute respiratory illness in the near two weeks.
(3) The infant belongs to a severe allergic constitution, and is allergic to the traditional Chinese medicine components.
1.4 Treatment regimen
The traditional Chinese medicine composition is used for treatment, and the ointment is prepared from the following medicinal materials of 50 parts of bighead atractylodes rhizome, 100 parts of Chinese yam, 40 parts of chicken's gizzard-membrane, 100 parts of radix pseudostellariae, 40 parts of grassleaf sweetflag rhizome, 50 parts of Jian qu, 50 parts of dahurian angelica root, 40 parts of platycodon root, 30 parts of figwort root, 50 parts of common selfheal fruit-spike, 100 parts of Ficus carica, 20 parts of dried orange peel, 30 parts of rhizoma pinellinae praeparata, 25 parts of striga asiatica, 50 parts of Indian buead, 90 parts of lotus seed, 50 parts of malt, 30 parts of clean hawthorn fruit and 90 parts of maltose.
The administration method comprises taking 20g each time, and adding 100-150 ml warm boiled water.
Once daily for the first week, and then up to twice daily, at least one complete dose, i.e. a minimum of 12 days.
1.5 Scoring criteria
The traditional Chinese medicine syndrome classification table is formulated according to the Chinese medicine new medicine clinical research guidelines, and contains main symptoms of snoring and/or breath during sleep, and the classification of 0,1,2 and 3 is respectively recorded according to 4 grades which are never or almost 1 month without symptoms, occasionally occur frequently. The secondary symptoms include apnea or awakening, wherein the number of the symptoms is respectively marked as 0,1,2 and 3 according to 4 grades which are never or nearly 1 month without symptoms, occasionally occur, frequently occur and always occur, the number of the symptoms is respectively marked as 0,1,2 and 3 according to 4 grades which are never or nearly 1 month without symptoms, occasionally occur, frequently occur, always occur, the size of the gland volume is respectively marked as 0,1,2 and 3 according to 4 grades which are more than 65-80 percent and 65-80 percent after the gland is blocked according to a fiber (electronic) nasopharyngoscope, the sum of the scores of the symptoms is the total integral of the symptoms, and the higher score indicates that the symptom is more serious, as shown in table 1.
TABLE 1
Wherein, occasionally, the finger is 1 to 2 times per 1 week, and frequently, the finger is 3 to 4 times per 1 week, and always, the finger is daily.
1.6 Treatment results
And calculating improvement rate according to the symptoms and sign scores before and after treatment, and evaluating the improvement degree. The improvement degree is divided into four stages, namely significant improvement, slight improvement, insignificant improvement and ineffectiveness.
Improvement rate = (pre-treatment score-post-treatment score)/pre-treatment score x 100%
The improvement degree is that 70% is obviously improved, 50% -70% is slightly improved, 30% -50% is not obviously improved, and <30% is ineffective.
The results were counted and the follow-up time of 50 subjects was 250 to 750 g of the paste prepared in example 1 taken completely, and the results are shown in Table 2.
Table 2 treatment results (n=50)
| Degree of improvement | Significantly improve | Slightly improve | Improvement is not obvious | Has no effect |
| Quantity (example) | 30 | 10 | 6 | 4 |
| Improving efficiency | 60% | 20% | 12% | 8% |
After the patient takes 250 g of the ointment prepared in the example 1, the overall treatment effective rate reaches 80 percent, and the obvious effective rate reaches 60 percent. The ointment is prepared by decocting and concentrating on the basis of a compound prescription and adding maltose refined ointment, treats the snore of children from the lung and spleen, achieves the effects of tonifying the lung and strengthening the middle-jiao, eliminating dampness and resolving phlegm, helps the children to improve other organism dysfunctions caused by bad life habits, and radically treats the snore of children.
1.7 Specific clinical examples;
Clinical example 1 yellow XX, men, 8 years old, 2024, 3 months, 19 days to visit, snoring with mouth opening breathing for 2 years during sleep, about 2-3 attacks in the first week, and later, the onset during night sleep every day without apnea or holding back, sleepiness in the daytime, inability to concentrate attention, and consistent height, weight and intelligence with the normal level of the same person. With itching nose, sneeze, general sleep, and constipation.
The examination of the body, in which the nasal septum is basically centered, the turbinates under the nose are swollen and pale, and no obvious secretion is seen in each nasal passage. The pharyngeal mucosa is free of congestion, the I degree of the double tonsils is large, the color is light red, and no pus spots and secretion are generated.
Intranasal endoscopy showed that the glands blocked 75% of the nostrils. A pale red tongue with thin and white coating and a thready pulse.
The Chinese medicine diagnosis includes snore, lung and spleen deficiency, western diagnosis including oral breathing and adenoid hypertrophy.
250 G of the paste prepared in example 1 was taken with warm water, 20g of the paste was taken once a week for 2 times a day, 20g of the paste was taken once a week, and 1 time a day after the second week.
Two diagnoses are performed in 2024 and 4 months and 2 days, the snoring is accompanied with the relief of mouth opening and breathing symptoms when the child patient sleeps, the attack is about 4-5 times a week, the nose is reduced before the child patient sleeps, no apnea or no breathing is caused, nose itching and sneeze are still caused, the child patient can receive the nose, and the child patient can sleep and can regulate the child patient's urine.
Examination of the body the nasal septum was basically resident, the turgescence of the lower nails was pale, and no obvious secretion was seen in each nasal meatus. The pharyngeal mucosa is free of congestion, the I degree of the double tonsils is large, the color is light red, and no pus spots and secretion are generated. The prescription is instructed to continue to take 250 g of the ointment, and 15g is taken once for 1 time a day until the taking is completed. Three times after two weeks, the symptoms are greatly relieved before the patients feel itchy nose and sneeze, the frequency of the sneeze is reduced, and the snoring and the breathing of the mouth are carried out for 1-2 times.
Clinical example 2 Tan XX, female, 4 years old, 2024, 3 months and 14 days to visit, snoring with mouth opening breathing for 1 month during sleep, about 3-4 times of attacks in one week, no apnea or suffocation, no conditions of daytime sleepiness, inattention, memory decline and the like are found, and the height, weight and intelligence are consistent with the normal level of the same person. Navigator, normal urination and rotten stool.
The examination of the body, in which the nasal septum is basically centered, the turbinates under the nose are swollen and pale, and no obvious secretion is seen in each nasal passage. The pharyngeal mucosa is free of congestion, the double tonsils are not big, the color is light red, and no pus spots and secretion are on the pharyngeal mucosa.
Intranasal endoscopy showed that the adenoids blocked 40% of the nostrils. A pale red tongue with thin and white coating and a thready pulse.
The Chinese medicine diagnosis includes snore and deficiency of lung and spleen qi. Western diagnosis, oral respiration.
250G of the paste obtained in example 1 was taken with warm water, 20g once a week and 2 times a day, 20g once a second week and 1 time a day until the administration was completed.
Re-diagnosis is performed in 2024 and 4 months and 12 days, and the snoring with mouth opening and breathing symptoms can be seen for 1-2 times a week during sleep, and the snoring is not started for most of the time.
Clinical example 3 warm XX, female, 3 years old, snoring with mouth opening breathing for 3 weeks during sleep, 1 month and 30 days of diagnosis in 2024, about 2-3 times of attacks in one week, no apnea or suffocation, no daytime sleepiness, inattention, memory decline and the like are found, and the height, weight and intelligence are consistent with the normal level of the same-age person. Generally, sleep, normal urination and rotten stool.
The examination of the body, in which the nasal septum is basically centered, the turbinates under the nose are swollen and pale, and no obvious secretion is seen in each nasal passage. The pharyngeal mucosa is free from congestion, and the double tonsils have large I degree and pale red color.
Intranasal endoscopy showed that the gland blocked 60% of the nostrils. A pale-red tongue with a thin and white coating and a thready and rapid pulse
The Chinese medicine diagnosis includes snoring and spleen deficiency and dampness obstruction. Western diagnosis, oral respiration.
250 G of the paste obtained in example 1 was taken with warm water 15g once a week and 2 times a day, 15g once a second week and 1 time a day until the administration was completed.
Re-diagnosis is performed at 2 months and 22 days 2024, the physical examination is basically the same as before, and the symptoms of snoring accompanied by mouth opening and breathing during sleep are basically disappeared. The prescription is prescribed to be continuously taken for 250 g, and the warm water is mixed for 10g once, 1 time a day, and the symptoms do not relapse during three diagnosis.
Clinical example 4. High XX, 5 years old, snoring with half a year of mouth breathing during repeated sleep, 2024, 2 months and 6 days. 3-4 times of attacks in one week, no apnea or no holding back, and occasionally, no concentration. Once with adenoidectomy, postoperative symptoms are repeated. Generally, sleep and coordination are achieved.
The examination of the body, in which the nasal septum is basically centered, the turbinates under the two noses are swollen, the color is light, and the total nasal meatus is yellow secretion. Bilateral tonsils are large in III degree and pale red. A pale red tongue with a thin and white coating and a thready and rapid pulse.
The Chinese medicine diagnosis includes snoring and spleen deficiency and dampness obstruction. Western diagnosis, oral respiration.
250G of the paste obtained in example 1 was taken with warm water 15g once a week and 2 times a day, 15g once a second week and 1 time a day until the administration was completed. Three weeks later, two diagnosis is carried out, snoring is improved along with mouth opening and breathing during sleep, and 1-2 times of attack are carried out in one week.
Clinical example 5 face XX, female, age 5, snoring with mouth opening breathing for more than 2 years, dry mouth, and visit at 1 month 31 of 2024. The first 2-3 times a week, the later development is daily, no apnea or suffocation is caused, no conditions such as daytime sleepiness, inattention, memory decline and the like are found, and the height, weight and intelligence are consistent with the normal level of the same-age people. Generally, sleep, normal urination and rotten stool.
The examination of the body, in which the nasal septum is basically centered, the turbinates under the nose are swollen and pale, and no obvious secretion is seen in each nasal passage. The pharyngeal mucosa is free from congestion, and the double tonsils have large I degree and pale red color.
Intranasal endoscopy showed that the adenoids blocked 70% of the nostrils. A pale red tongue with a thin and white coating and a thready and rapid pulse.
The Chinese medicine diagnosis includes snoring and spleen deficiency and dampness obstruction. Western diagnosis, oral respiration.
250G of the paste obtained in example 1 was taken with warm water 15g once a week and 2 times a day, 15g once a second week and 1 time a day until the administration was completed. Two weeks later, the snoring with open mouth and respiratory symptoms is completely relieved during sleep, and no recurrence is seen.
Clinical example 6 thank to XX, female, 6 years old, 3 weeks after adenoidectomy, 1 week with open mouth breathing, occasional snoring, 20 days 2 in 2024. About 2-3 times of 1 week of attack, and no other accompanying symptoms.
The examination of the body, middle nasal septum, enlarged lower nasal turbinates, pale color, white secretion seen in each nasal meatus. The pharynx is slightly engorged with little tonsil, and the back wall of the pharynx shows hyperplasia of lymphatic follicles. A pale red tongue with white coating and a thready and rapid pulse.
The Chinese medicine diagnosis includes snore and deficiency of lung and spleen qi. Western diagnosis, oral respiration.
250G of the paste obtained in example 1 was taken with warm water 20g once a week and 2 times a day, 15g once a second week and 1 time a day until the administration was completed. Two weeks later, the snoring and the mouth opening breathing symptoms are completely relieved during sleep, and no recurrence is seen.
The above description is only of the preferred embodiments of the present invention and is not intended to limit the present invention, but various modifications and variations can be made to the present invention by those skilled in the art. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (10)
1. The traditional Chinese medicine composition for treating the pediatric snoring is characterized by comprising, by weight, 40-60 parts of bighead atractylodes rhizome, 80-100 parts of Chinese yam, 20-50 parts of chicken's gizzard-membrane, 80-100 parts of radix pseudostellariae, 20-40 parts of grassleaf sweelflag rhizome, 20-50 parts of Jianqu, 40-60 parts of radix angelicae, 30-50 parts of platycodon grandiflorum, 20-40 parts of radix scrophulariae, 20-55 parts of selfheal, 80-100 parts of Ficus simplicissima, 15-35 parts of dried orange peel, 20-30 parts of rhizoma pinellinae praeparata, 15-30 parts of striga, 30-50 parts of poria cocos, 70-100 parts of lotus seeds, 45-65 parts of malt, 25-35 parts of net hawthorn and 80-110 parts of maltose.
2. The traditional Chinese medicine composition for treating the pediatric snoring according to claim 1 is characterized by comprising, by weight, 45-55 parts of bighead atractylodes rhizome, 90-100 parts of Chinese yam, 30-45 parts of chicken's gizzard-membrane, 95-100 parts of radix pseudostellariae, 35-40 parts of grassleaf sweelflag rhizome, 40-50 parts of Jianqu, 45-55 parts of radix angelicae, 35-45 parts of platycodon grandiflorum, 25-35 parts of radix scrophulariae, 45-55 parts of selfheal, 90-100 parts of Ficus simplicissima, 15-20 parts of dried orange peel, 25-30 parts of rhizoma pinellinae praeparata, 20-30 parts of strigosae, 45-50 parts of poria cocos, 80-95 parts of lotus seeds, 45-50 parts of malt, 25-30 parts of net hawthorn and 80-100 parts of maltose.
3. The traditional Chinese medicine composition for treating the pediatric snoring according to claim 1 is characterized by comprising the following raw materials, by weight, 50 parts of bighead atractylodes rhizome, 100 parts of Chinese yam, 40 parts of chicken's gizzard-skin, 100 parts of radix pseudostellariae, 40 parts of grassleaf sweelflag rhizome, 50 parts of Jianqu, 50 parts of dahurian angelica root, 40 parts of platycodon root, 30 parts of figwort root, 50 parts of common selfheal fruit-spike, 100 parts of figwort root, 20 parts of dried orange peel, 30 parts of rhizoma pinellinae praeparata, 25 parts of striga asiatica, 50 parts of poria cocos, 90 parts of lotus seed, 50 parts of malt, 30 parts of net hawthorn and 90 parts of maltose.
4. Use of a traditional Chinese medicine composition according to any one of claims 1-3 for preparing a medicament for treating pediatric snoring.
5. The use according to claim 4, wherein the pediatric snoring condition comprises pediatric adenoids and tonsillar hypertrophy.
6. A medicament for treating pediatric snoring, which is characterized by comprising the traditional Chinese medicine composition for treating pediatric snoring as claimed in any one of claims 1-3 and pharmaceutically acceptable auxiliary materials;
The auxiliary materials comprise at least one or more of disintegrating agents, emulsifying agents, filling agents, flavoring agents, wetting agents, binding agents, absorption promoters, coloring agents and cosolvent.
7. The medicine for treating pediatric snoring as defined in claim 6, wherein the dosage form of the medicine comprises one or more of a paste, decoction, granule, pill, capsule, tablet, mixture, suspension, powder or oral liquid.
8. The medicament for treating pediatric snoring as defined in claim 6, wherein the medicament is a medicament for ameliorating snoring at sleep, open mouth breathing, abnormal sleep breathing, enuresis, impaired attention, hyperactivity, somnolence, behavioral and emotional disorders, adenoids and tonsillar hypertrophy.
9. The method for preparing the medicament for treating the pediatric snoring according to any one of claims 6 to 8, wherein the method for preparing the medicament is as follows:
weighing all the raw materials except maltose according to the weight portion, adding purified water and soaking;
Step two, extracting the crude drugs for three times, collecting the extracting solution and filtering;
And thirdly, adding maltose after filtering and concentrating to obtain the product.
10. The method for preparing a medicament for treating pediatric snoring as defined in claim 9, wherein the step one comprises adding 6 times of water into the raw materials for at least 12 hours;
The extraction process in the second step comprises collecting liquid medicine after 1.5 hours of first decoction, collecting liquid medicine after 1 hour of second decoction and adding 6 times of water of the total raw materials, and collecting liquid medicine after the third decoction and adding 3 times of water of the total raw materials, collecting liquid medicine after 1 hour of decoction, combining the three extraction filtrates, and filtering.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202411371932.7A CN119097678A (en) | 2024-09-29 | 2024-09-29 | A Chinese medicine composition for treating pediatric snoring and its application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202411371932.7A CN119097678A (en) | 2024-09-29 | 2024-09-29 | A Chinese medicine composition for treating pediatric snoring and its application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN119097678A true CN119097678A (en) | 2024-12-10 |
Family
ID=93717327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202411371932.7A Pending CN119097678A (en) | 2024-09-29 | 2024-09-29 | A Chinese medicine composition for treating pediatric snoring and its application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN119097678A (en) |
-
2024
- 2024-09-29 CN CN202411371932.7A patent/CN119097678A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1899550A (en) | External plaster for treating child cold type cough and preparing method | |
| CN110721303A (en) | Traditional Chinese medicine composition for treating allergic rhinitis and application thereof | |
| CN112717113B (en) | Traditional Chinese medicine composition for treating allergic rhinitis and paste formula and application thereof | |
| CN105148210A (en) | Chinese medicine for treating cough and preparation method thereof | |
| CN104922346A (en) | Traditional Chinese medicine for treating chronic pharyngitis | |
| CN104042713B (en) | A kind of Chinese medicine composition for the treatment of bronchial asthma | |
| CN118044611A (en) | Lung-clearing and lung-protecting nutrition product | |
| CN100455319C (en) | A traditional Chinese medicine preparation for treating cough in children and its preparation method | |
| CN119097678A (en) | A Chinese medicine composition for treating pediatric snoring and its application | |
| CN102885946A (en) | Chinese medicament for treating cough and asthma | |
| CN118453820B (en) | Traditional Chinese medicine composition and traditional Chinese medicine patch for treating infantile colic and preparation method thereof | |
| CN105106508A (en) | Cocklebur fruit allergic rhinitis paste | |
| CN104857414A (en) | Medicine composite for treating chronic simple rhinitis | |
| CN104189605A (en) | Traditional Chinese preparation for treating acute nasopharyngitis and preparation method thereof | |
| CN104367975A (en) | Flos farfarae paste for relieving cough and eliminating phlegm | |
| CN104547642A (en) | Tradtional Chinese medicine composition for treating female fibromyalgia syndromes | |
| CN115463203B (en) | Traditional Chinese medicine composition for preventing children influenza | |
| CN103656459B (en) | A traditional Chinese medicine for treating cough due to deficiency of both lung and spleen | |
| CN108815226A (en) | A kind of gynemetrics's drug and preparation method thereof for treating endocrine disorder | |
| CN108126117A (en) | A kind of Chinese medicine composition for treating cerebral infarction | |
| CN114848788A (en) | Cortex lycii radicis powder decoction as well as preparation method and application thereof | |
| CN107596184A (en) | A kind of pill medicine for treating allergic rhinitis and preparation method thereof | |
| CN106421411A (en) | Stomach tonifying functional beverage | |
| CN119386132A (en) | A Chinese medicine composition, ointment and application thereof | |
| CN105168860A (en) | A traditional Chinese medicine composition for treating asthma in children and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |